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To investigate structure and biological properties of the nucleocapsid (N) protein of respiratory syncytial virus (RSV), we
have generated a panel of 16 monoclonal antibodies, raised against recombinant N protein, and epitope mapped seven of
these to three antigenic sites (Site I aa 16–30; Site II aa 341–350; Site III aa 351–365). Characterization by immunofluores-
cence and by immunoprecipitation assay demonstrated that a monoclonal antibody to antigenic site I can detect N protein
complexed with phospho (P) protein. Antibodies to antigenic sites II and III, which are adjacent to each other near the
carboxyl terminus of the N protein, have distinct properties. A site III monoclonal antibody detected N protein in cytoplasmic
inclusion bodies and in the cytosol, but not when N was complexed to P protein, while the site II antibody reacted with N
protein in the nucleocapsid fraction but did not detect cytosolic N protein. Further investigation into the reactivities of the
antibodies after binding of P to N in vitro demonstrated that antigenic sites II and III were blocked by the interaction,
indicating an involvement for the carboxy domain of N in the N–P interaction. This was confirmed by the ability of peptides
from the carboxy terminus of N to inhibit the N–P interaction in vitro. © 2001 Academic Press
Key Words: RSV; nucleocapsid; N–P interaction; monoclonal antibodies; peptides; P binding.
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Respiratory syncytial virus (RSV), genus Pneumovirus,
family Paramyxoviridae, is a major cause of lower respi-
ratory tract infection in humans, particularly infants, and
has been implicated as a cause of respiratory failure in
elderly institutionalized people (Simoes, 1999). The virus
has an RNA genome (Collins et al., 1995) that is coated
with nucleocapsid (N) protein to form a helical ribonu-
cleoprotein complex termed the nucleocapsid (Meric et
al., 1994). The nucleocapsid, which protects the RNA
genome from ribonucleases, is associated with other
viral proteins (P, M2, and L), which form the transcriptase
complex. The nucleocapsid is the template for transcrip-
tion and replication; the RNA genome by itself cannot
fulfill the role of template. RSV infection of cells results in
the accumulation of N protein in cytoplasmic inclusion
(CI) bodies that can be visualized by immunofluores-
cence assay (IFA) as relatively large dots that are usually
close to the nucleus of infected cells (Garcia et al., 1993;
Norrby et al., 1970). The CI bodies stain positively for the
P protein and for the M2-1 protein, suggesting that they
may be sites where replication and transcription of the
RNA genome takes place, though this has not been
conclusively demonstrated.M
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252Expression of N proteins from a number of nonseg-
mented, negative-sense RNA viruses, including RSV,
demonstrates that, in the absence of viral RNA or other
viral proteins, nucleocapsid-like structures are formed by
illegitimate assembly on cellular RNAs. These structures
would appear to be morphologically (as visualized by
electron microscopy), and antigenically, identical to nu-
cleocapsids extracted from virally infected cells (Buch-
holz et al., 1993; Meric et al., 1994; Iseni et al., 1998;
pehner et al., 1997; Warnes et al., 1995). Within infected
ells only the viral genomic and antigenomic RNAs are
ncapsidated, probably by interaction with specific mo-
ifs on the RNA, particularly in the leader regions. It has
een proposed that a function of P may be as a molec-
lar chaperone for N such that it is an N–P complex that
s responsible for the specificity for the encapsidation of
iral RNAs, and for the delivery of N to assembling
ucleocapsids after which the majority of P proteins
robably dissociate. This functionality required different
omains on P than those necessary when it formed part
f the transcriptase/replicase complex. Thus there are
undamental differences between soluble N–P and the
ucleocapsid-bound N–P complex (Curran et al., 1995;
pehner et al., 1997). The N of measles, when expressed
lone, was also observed to accumulate into inclusion
odies, whether these are directly comparable to the CI
odies found during measles infection is not known.
apping of N proteins indicates that N has two major
omains; the amino terminal domain appears to be re-
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253P BINDING DOMAIN ON N PROTEINquired for nucleocapsid formation, containing the do-
mains necessary for RNA binding and N–N interactions,
while the carboxy domain interacts with the P, particu-
larly when it is part of the polymerase (Curran et al., 1995;
omann et al., 1991; Ryan et al., 1993). For RSV a few
eatures of the P protein’s relationship with N have been
etermined. Namely, that the carboxy tail of P was im-
ortant for an interaction with N and that inclusion bod-
es formed as a result of coexpression of N and P.
owever, regions on N responsible for binding P were
ot defined (Garcia-Barreno et al., 1996). In this report we
escribe the characterization of a number of monoclonal
ntibodies (Mabs) targeted against the N protein of RSV.
his paper describes the biological features of some of
he Mabs and indicates how they may help in under-
tanding the structure/function relationship of the RSV N
rotein during assembly and when interacting with other
omponents of the virus. The N–P interaction is shown to
nfluence the reactivities of some of the Mabs and we
dentify a candidate region in the carboxyl terminus of N
or binding P protein.
RESULTS AND DISCUSSION
ntibody production and epitope mapping
Recombinant N and P proteins containing histidine
T
Reactivities of the M
Mab ELISA RIPA W/Bl
aN002a 11 2 11
aN003 11 1 11
aN004 2 2 1
aN005b 1 1 1
aN006 2 2 11
aN007 11 2 1
aN008 11 2 1
aN009a 11 11 11
aN010b 11 2 11
aN011 2 2 11
aN012 2 2 11
aN013 2 2 11
aN014 11 1 11
aN015a 11 2 11
aN016 11 1 1
aN017 2 2 1
aP001 111 111 11
Note. Each of the Mabs was tested in a series of immunological ass
nd Western blot) or in RIPA buffer. For IFA, infected cells were fixed wit
n each assay; a negative sign denotes no reactivity. For positions of th
or location on the N protein. NR, not reactive with any peptides. N/A,
a The N protein Mabs used in this study and the location of the ant
b aN005 and aN010 were partially mapped using carboxy terminal m
ot shown).ags at their amino termini were purified using standard
ickel affinity chromatography on a Pharmacia AKTA 3PLC system. The purity of the proteins was estimated
y Coomassie blue staining, following SDS–PAGE, to be
bove 95%. New Zealand White rabbits were used for the
eneration of polyclonal antisera, designated NRP14 for
he anti-N polyclonal and PRP658 for the P antiserum.
onoclonal antibodies were isolated after inoculation of
ALB/c mice. The specificities of the Mabs against the N
rotein were determined in a number of immunological
ssays (Table 1) using RSV-infected A549 cells as source
f antigen. All the Mabs obtained were reactive against
SV N protein in Western blot assays, indicating that they
re most likely targeted against linear, rather than con-
ormational, epitopes. To map the N protein Mab
pitopes, a peptide scanning protocol was used. Twenty-
ix overlapping peptides that represented the 391 amino
cid sequence of the N protein were used to identify the
mmunological targets. Seven out of 16 Mabs could be
apped using this method with three peptides, N2, N23,
nd N24, identified as containing the epitopes. The Mabs
id not react with adjacent peptides, suggesting that the
ctual epitopes lie largely, or wholly, within the unique 10
mino acid region of each of the peptides. The Mabs
solated in this study identified at least three, and pos-
ibly as many as five, distinct antigenic sites on the N
rotein of RSV (Fig. 1). Antigenic site I (aN009 and
aN011) is contained within amino acids 16–35 (N2); an-
tained in this Study
IFA Peptide Antigenic site
1 N24 III, 346–365
111 N24 III, 346–365
2 NR Unknown
2 NR ?, 1–100
2 NR Unknown
2 NR Unknown
11 NR Unknown
111 N2 I, 16–35
2 NR ?, 1–100
2 N2 I, 16–35
2 NR Unknown
11 NR Unknown
11 N24 III, 346–365
111 N23 II, 331–350
2 NR Unknown
11 N24 III, 346–365
111 N/A N/A
ainst RSV-infected A549 cell lysates prepared either in PBS (for ELISA
anol. The number of plus signs indicates the strength of the interaction
ides that were reactive in the Mab mapping experiment refer to Fig. 1
plicable.
ites.
of the N protein expressed in E. coli in a Western blot assay (detailsABLE 1
abs Ob
ot
1
1
1
ays ag
h meth
e pept
not ap
igenic stigenic site II (aN015) is contained within amino acids
31–350 (N23), while antigenic site III (aN002, aN003,
3nding to
254 MURRAY ET AL.aN014, and aN017) is located within amino acids 346–
65 (N24). A further two Mabs, aN005 and aN010,
mapped within amino acids 1–100 using truncated N
mutants in a Western blot assay (J. Murray and L. B.
Murphy, data not shown). Whether they mapped to anti-
genic site I or to other sites could not be determined, as
no binding to any peptide could be demonstrated. Not all
the Mabs from a single antigenic site display identical
properties; aN002, aN003, aN014, and aN017 from anti-
genic site III have different reactivities in the various
assays (see Table 1) and they might recognize different
epitopes within antigenic site III. Peptides N23 and N24
may represent a single antigenic site but, for this study,
since no cross reactivity with the respective Mabs was
observed, we have regarded them as two distinct sites.
It would be interesting to further define the true nature of
aN005 and aN010 as to whether they interact with dis-
tinct immunological targets or are also members of the
antigenic site I group.
IFA of N protein in RSV-infected cells
Since the Mabs map to at least three antigenic sites
and represent the amino and carboxy domains of the N
protein, it was of interest to determine whether they had
FIG. 1. Location of the antigenic sites I to III and peptides used in t
“LYDAA” is shared between peptides N23 and N24 and may form part
interaction (see text and Fig. 4d) are shown and represent amino acids
coordinates that each peptide covers. The region that affects the P bi
shaded.different biological features that might be useful in de-
termining structure/function relationships. Using IFA, theintracellular distribution of the N protein was visualized
in infected A549 cells using representative Mabs from
each of the antigenic sites (Fig. 2). It was observed that
Mabs aN009 (site I, amino terminal, Fig. 2a) and aN003
(site III, carboxyl-terminal, Fig. 2c) appear to have similar
staining patterns. The CI bodies (potential sites of viral
replication) are visualized as spherical structures near
the nucleus of the cell (arrows), as previously described
by Garcia et al. (1993). Staining is also apparent in the
cytosolic region and around the periphery of the cell in
spike-like structures, commonly referred to as filamen-
tous virus, presumably representing nucleocapsids in
the final stages of virion assembly before budding. Mab
aN015 (site II, again carboxyl terminal, Fig. 2b) also
stains the CI bodies and the membrane, but unlike the
other Mabs, aN015 does not show any significant cyto-
plasmic staining, suggesting that it may detect a different
form of the N protein.
Treatment of the infected cells with cycloheximide,
which prevents further protein synthesis but allows mat-
uration and assembly to proceed, causes a change in
aN003’s and aN009’s staining pattern (Figs. 2d and 2f).
They now appear similar to aN015 with, or without, cy-
cloheximide treatment (Figs. 2b and 2e), namely that the
y. The antigenic sites are in bold and boxed; note that the sequence
enic sites II and III. The peptides (black lines) used to block the N–P
e carboxy domain of the N protein; the numbers refer to the N protein
N, as determined by the peptide blocking experiment, is boxed andhis stud
of antig
from thN staining of the cytosol has now significantly dimin-
ished but the stain remains in the CI bodies and around
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255P BINDING DOMAIN ON N PROTEINthe plasma membrane. It is likely that the cytosol repre-
sents a pool of soluble N, which by analogy to Sendai
virus may be complexed to P protein, while the CI bodies,
and the N protein associated with the plasma mem-
brane, are likely to consist of nucleocapsids ready to bud
into virions. This suggests that Mab aN015 can detect an
pitope that may only be available on a more mature
orm of N protein such as the nucleocapsid. The epitope
or aN015 may only become available due to a confor-
mational change by the N protein or the epitope previ-
ously blocked by some other component (most likely the
P protein) being revealed during nucleocapsid assembly.
Immunoprecipitation of N from infected cell lysates
The relationship between the Mabs and the N–P in-
teraction was further investigated using radioimmuno-
precipitation assay (RIPA). The protocol employed a
500,000 g spin that should pellet assembled nucleocap-
sids (being large macromolecular complexes), leaving a
pool of “free” N protein in the cytosolic supernatant (sup-
posedly uncomplexed N and N–P); the pellet was re-
tained and resolubilized into RIPA buffer. If the hypothe-
sis is that aN015 identifies an epitope on the nucleocap-
FIG. 2. The effect of cycloheximide on the intracellular distribution of
at an m.o.i. of 1.0 for 16 h, after which the medium was replaced a
cycloheximide at 100 mg/ml21. The infected cells were probed with an
conjugate. All washes and addition of antibodies were performed in
olution and visualized using a Zeiss confocal microscope and images
orm presumably by the aggregation of nucleocapsids.id, then there should be a difference in reactivity when
he cytosolic and pelleted fractions are compared. The
a
ibility of the Mabs to precipitate N protein when ex-
ressed alone was also tested by using a recombinant
aculovirus expressing the RSV N protein. Figure 3b
llustrates that aN003 and aN009 react equally with cy-
osolic N (that is, N derived from a post 500,000 g super-
atant) when expressed in the baculovirus system.
aN015 (Fig. 3b) has a comparatively poor reactivity in a
RIPA but was still able to detect soluble N protein. A
different situation occurred when RSV-infected A549
cells were analyzed. In Fig. 3a aN009 precipitated P with
N from the cytosolic fraction, while aN003 demonstrated
a reduced ability to pull down N (but not P), unlike the
baculovirus situation where aN009 and aN003 precipi-
tated equivalent amounts. Thus there appears to be
some factor preventing aN003 from effectively pulling N
from the soluble fraction prepared from RSV-infected
A549 cells. aN015 appears to be unable to pull down any
from the soluble fraction. When we look at the pelleted
raction, which may represent assembled nucleocapsids,
ll three Mabs react with N protein. aN003 still reacts
poorly but now aN015 pulls down N protein, suggesting
hat aN015 can differentiate between the forms of N
within the two fractions. Similar to aN003, we see no
protein. A549 cells, grown on glass coverslips, were infected with RSV
infection was continued in the presence (d–f) or absence (a–c) of
bs after fixation with methanol and detected with an anti-mouse FITC
2% (v/v) FCS. The stained coverslips were mounted in PBS/glycerol
ed using the LSM 510 software. The arrows indicate the CI bodies thatthe N
nd the
ti-N Ma
PBS 1ssociation of P with N. If the pelleted fraction does
ndeed contain nucleocapsids, we might have expected
da
o
P
t
t
a
p
a
p
p
P
N
a
e
u
d
a
a
t
s
b
M
c
i
R
w
d
m
s
(
00-g ce
t preci
256 MURRAY ET AL.coprecipitation of nucleocapsid-bound P. The lack of P
coprecipitated by aN015 may be a result of P being
isplaced, whereas aN009 had no effect on nucleocap-
sid-associated P. Ryan et al. (1993) describe how Mabs
to the carboxy region of Sendai virus N displaced P from
nucleocapsids. So, similar to Sendai virus, the carboxy
region of the RSV N protein is important in the N–P
interaction. For aN015 we note that it weakly precipitates
N from the Bac-Nwt (Fig. 3b); thus, the band pulled down
by this Mab from the pelleted fraction represents a sig-
nificant pull down of N protein, strengthening the sug-
gestion that aN015 identifies an epitope that may only be
vailable on N after disassociation of the P, which would
ccur during nucleocapsid assembly.
Densitometric analysis of the intensities of the N and
bands was performed to determine the molar ratio of
he N–P complex within the soluble fraction. The ratio of
he N and P bands (after adjusting for differences in sizes
nd methionine content and averaged from multiple ex-
eriments) pulled down by the N polyclonal antiserum
nd by Mab aN009 demonstrate a stoichiometry of 1 N
rotein to 1.3–1.5 P proteins However, when the anti-P
rotein polyclonal was used in IP, the ratio was 1 N to 0.7
proteins. This suggests that there may be an excess of
protein over the P protein (and not complexed to it),
ssuming that the polyclonal to the P protein is still as
ffective when P is bound to N protein. The anti-P Mab
FIG. 3. RIPA using Mabs from each antigenic site. (a) RIPA of the s
fractions of RSV-(I) and mock-infected (M) A549 cells after radiolabeling
the primary antibodies for 1 h before a further 2-h incubation with Prote
the N and P, respectively; P Mab is a monoclonal antibody to the RSV P.
the samples were separated by electrophoresis on 12.5% SDS–PAGE.
phosphorimaging. (b) RIPA of SF21 cells infected with Bac-Nwt. Sf21 c
RSV N protein. After radiolabeling the lysate was subjected to a 500,0
pull down was observed with the P Mab, showing that aN015 is in facsed in this study reacts differently, this time pulling
own significantly more P than N. The implication is thatproportion of N and P in the cytosol is uncomplexed,
lthough aN003 indicates that the amount of uncom-
plexed N is low.
The data for Mabs aN003 and aN015 suggest that
heir epitope targets may be exposed on the nucleocap-
id, or rather that the epitope is revealed during assem-
ly probably by dissociation of P. The reactivity of the
abs to nucleocapsids was tested by isolating nucleo-
apsid-like structures, formed in insect cells that were
nfected with a recombinant baculovirus expressing the
SV N protein, in a capture ELISA. Ribonucleoproteins,
ith a density of 1.29 g/cm3, were isolated on CsCl
ensity gradients and dialyzed against PBS. Electron
icroscopy confirmed the presence of nucleocapsid-like
tructures (not shown, Meric et al., 1994). The isolation
on such gradients separates soluble, monomeric N pro-
tein from the nucleocapsid-like structures; size exclusion
chromatography of such preparations did not show any
evidence for an N protein species less than 5 3 105 Da
R. P. Yeo, unpublished results; N is 4 3 104 Da). Micro-
titer plates coated with the appropriate antibodies were
used to capture N from such a preparation, which was
then detected using the polyclonal antiserum aNRP14.
As can be seen in Fig. 4a, all the Mabs were able to
capture this assembled form of N, suggesting that the
epitopes would also be available on nucleocapsids
formed in RSV-infected cells.
cytosolic, post 500,000 g supernatant) and pelleted (500,000 g pellet)
S]methionine and lysis in RIPA buffer. The lysates were incubated with
pharose. RPN14 and P poly refer to rabbit polyclonal antisera against
ashing and resuspension of immunocomplexes in SDS loading buffer,
l was fixed and dried before visualization of radiolabeled products by
re infected for 3 days with a recombinant baculovirus expressing the
ntrifugation step and the supernatant retained and used for RIPA. No
pitating N.oluble (
with [35
in A Se
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The ge
ells weAt this stage it is hard to reconcile the differences
between aN003 and aN015, as they recognize epitopes
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257P BINDING DOMAIN ON N PROTEINclose together at the carboxyl terminus of N. In IFA,
aN015 identifies N in CI bodies and around the periphery
FIG. 4. (a) The Mabs can bind to purified, recombinant nucleocap
expressing the N protein, were isolated on CsCl gradients and capt
detected using a rabbit polyclonal (RPN14) to the N protein and an an
availability of the epitopes on nucleocapsids. A P Mab was used as a no
plates was tested. The binding of Mabs to immobilized NHis protein was
sed are all reactive in ELISA. Wells were also coated with PHis protein
polyclonal antiserum (NRP14). BG represents background, i.e., no prima
complex; again anti-mouse HRP was used to detect binding (gray bars).
but less so with aN009. (c) Microtiter plates coated with Mabs were use
by probing with the NRP14 antiserum (black bars). NHis captured by eac
etected using the anti-P polyclonal antiserum, PRP658 (gray bars). Th
locking effect on the N–P interaction than does aN009. The P Mab w
amounts, determined empirically, of NHis, PHis, or Mab were used. (d) I
was used to coat microtiter plates and preincubated each of the peptid
of peptide and allowed to bind for 1 h. After washing, bound NHis was d
degree of color change, readout at 405 nm. Only N21 and N22 had a
Fig. 1 and the binding reaction was performed in PBS. In peptides N20,
but are not presented for reasons of clarity. The background was determ
Glasgow).of the cell, while aN003 also identifies N in the cytosol,
uncomplexed with P, suggesting that there is a differencebetween the various states of N, possibly conformational
in nature. Cash et al. (1979) demonstrated that during
ucleocapsids, produced in SF21cells by a recombinant baculovirus
Mabs coated onto microtiter plates. Captured nucleocapsids were
it HRP conjugate. All the Mabs were able to bind, demonstrating the
fic control. (b) The reactivity of Mabs to N coated directly onto microtiter
d by an anti-mouse HRP conjugate (black bars) showing that the Mabs
d to capture NHis, the binding of which could be detected by the anti-N
ody added. The Mabs were tested for their ability to react with the N–P
P interaction has a blocking effect on the binding of aN003 and aN015
ture NHis protein. The ability of the Mabs to capture NHis was confirmed
e Mabs was tested for its ability to bind PHis, the binding of which was
capture NHis but again aN003 and aN015 have a significantly greater
as a control to determine background binding. In b and c, saturating
blocking by peptides from the carboxyl terminus of the N protein. PHis
dilution range from 0.1 to 100 mg/ml. NHis was added in the presence
d using the rabbit polyclonal RPN14. Reactivity was determined by the
ive effect on the N–P interaction. The peptides used are described in
25, and N26, they did not show any ability to block the N–P interaction
sing a nonspecific peptide (a gift from H. Marsden, MRC Virology Unit,sids. N
ured by
ti-rabb
nspeci
detecte
and use
ry antib
The N–
d to cap
h of th
e Mabs
as used
n vitro
es in a
etecte
disrupt
N24, Ninfection the RSV N protein undergoes a transition from
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258 MURRAY ET AL.as a result of a conformational change. The species
precipitated by aN009 and aNRP14 within the baculovi-
rus system included a product of approximately 30 kDa
not present in the lanes for aN003 and aN015 (Fig. 3b).
This suggests that the carboxy domain is sensitive to
proteolytic removal, which had been previously demon-
strated for Sendai N (Heggeness et al., 1981). It has been
reported for rabies virus and measles virus that their N
proteins undergo conformational changes during nucleo-
capsid assembly (Gombart et al., 1993; Kawai et al.,
1999).
Blocking of the N–P interaction in vitro
From the RIPA data it appears that the N–P association
affects the reactivity of Mabs in the carboxy region. To
further test this, the ability of the Mabs to bind N protein
in the presence of P protein in vitro was investigated.
Microtiter plates were coated with recombinant PHis pro-
ein. No cross-reactivity was observed in control exper-
ments with any of the Mabs or polyclonal antisera nor
id the NHis or PHis proteins bind to nonspecific controls,
.g., BSA (not shown). The Mabs could be shown to bind
captured directly on the plate (Fig. 4b, black bars),
emonstrating that they were active in the ELISA assay.
he reactivities of the Mabs, however, were significantly
ifferent when NHis was captured by the immobilized PHis.
Notably aN003 and aN015 fail to bind to NHis that is
captured by PHis protein. aN009 binding would not ap-
ear to be significantly affected by the N–P interaction,
s would be predicted by the RIPA data above. When the
xperiment was reversed, with NHis captured by the
Mabs, PHis binding to NHis was prevented if aN003 and
aN015 were used to capture NHis (Fig. 4c). The Mabs
could be demonstrated to have captured the NHis protein
as the NRP14 polyclonal antiserum detected the cap-
tured NHis (black bars). Again aN009 was not affected by
the interaction. Thus aN003 and aN015 are affected by,
and they affect, the binding of P to N. Goto et al. (2000)
ave described antibodies to two antigenic sites on the
abies virus N protein. Antibodies to antigenic site IV on
he rabies virus N protein only recognize N protein in a
ature form, which could be analogous to antigenic site
I on the RSV N protein. They argue that this is due to a
onformational change within the N protein during nu-
leocapsid assembly. However, our data for aN003 and
aN015 tends to support the idea that their reactivities are
probably due to the unmasking of epitopes during nu-
cleocapsid assembly, although what form of N that
aN003 sees in the cytosol is unclear and still under
investigation.
Mabs aN003 and aN015 bind close to the P binding
site on the N proteinThe observations above raise the possibility that the P
binding site on the N protein is located in the carboxylterminus, in an analogous location to other members of
the Mononegavirales. Garcia-Barreno et al. (1996) dem-
nstrated that a P binding site might occur near amino
cid 352 of the RSV N protein (found with antigenic site
II described here). Using peptides that represent the
arboxyl terminus of the N protein (N16–N26, aa 226–
92; Fig. 1), we found that two peptides, N21 and N22,
epresenting amino acids 305–335, had a blocking effect
n the N–P interaction in vitro. These are adjacent to,
nd overlap with, the peptide to which aN015 binds, i.e.,
antigenic site II. As shown in Fig. 4d, addition of the N22
peptide blocks recombinant NHis protein from binding to
immobilized PHis protein in a dose-dependent manner,
ith 50% of the binding occurring at ,10 mg/ml of pep-
tide. N21 has a weaker ability to block with approxi-
mately 70 mg/ml required to reduce binding to 50%. The
specificity of the block was confirmed as the presence of
the N21 and N22 peptides did not interfere with the
interaction between N protein and the aN015 Mab (not
hown). Other peptides from this region (aa 222–392,
esignated N16–N26, not shown in Fig. 4d for clarity)
ave no effect on the N–P interaction in vitro. Thus it is
ikely that P binds to a region defined by peptides N21
nd N22 and that the blocking of aN003 and aN015 by P
protein is an effect of steric hindrance. N21 and N22 are
20-mer peptides that have a five amino acid overlap (aa
316–320 of the N protein sequence) and due to the
blocking activities it is possible that the region involved
in P protein binding includes the sequence shared be-
tween both peptides (aa 316–320 inclusive, QFPHS
shown boxed and shaded in Fig. 1), but probably extends
more into peptide N22. Khattar et al. (2000), using dele-
tion mutants of the N protein in the bovine RSV rescue
system, have also implicated a region of the carboxyl
terminus (amino acids 338–364) as being important for
the N protein’s interaction with P. Notably, antigenic sites
II and III fall within this region (341–365) and peptide N22
is very close. A second domain, amino acids 244–290,
was also identified as being involved; however, we do
not have supporting evidence for this domain. Peptides
N16 and N18, that represent part of this region, show no
blocking activity; however, there are gaps in our analysis
of this region since the intervening peptides (N17 241–
260 and N19 271–290) were not suitable for study, due to
solubility problems. If the region involved falls within the
unique 10 amino acids (246–255 and 276–285) of the
excluded peptides, then an interacting region may be
missed. It is significant, though, that the region defined
by Khattar et al. (2000) is close to the one identified
within this study. It may be possible that deletions of the
N protein in this area may cause localized misfolding,
thus blocking the P protein binding site. Krishnamurthy
and Samal (1998) showed that up to 32 amino acids
could be deleted from the carboxy domain of bovine RSV
without ablating the N–P interaction. The results pre-
sented here do not exclude the possibility that multiple
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259P BINDING DOMAIN ON N PROTEINregions of the N protein may be involved in binding of the
P protein. Garcia-Barreno et al. (1996) demonstrated that
a deletion of six amino acids at the amino terminus of N
affected the binding of P. This mutant, however, unlike
full-length N, no longer needed P to form CI bodies,
indicating that the two regions may have different func-
tions that cannot be detected in the in vitro analysis
performed here.
The ability to inhibit the P binding to N using soluble
peptides suggests a potential for an anti-RSV therapeu-
tic. If the N–P interaction could be blocked, using either
smaller peptides than those used here or a small mole-
cule designed on the basis of the P protein–peptide
interaction, it could inhibit replication of the virus. For
RSV there is need for an effective antiviral agent and
identification of small molecules that interfere with viral
protein–protein interactions would be beneficial. Prob-
lems arise with delivery; the molecule must be able to
bypass the cell lipid membrane and current work is
attempting to address this issue.
To summarize, we have developed a series of mono-
clonal antibodies to the N protein of RSV. Characteriza-
tion has demonstrated at least three antigenic sites with
distinct biological features. Two of the antigenic sites are
blocked by the binding of P protein implicating a domain
in the carboxy region of the N protein as being involved
in the interaction. Antigenic sites II and III appear to have
a conformational aspect that allows us to distinguish
between N in the cytosol and that bound to nucleocap-
sids. The antibodies, together with peptide blocking as-
says, identify a site within the carboxy domain of the N
protein for binding P protein.
MATERIALS AND METHODS
Virus and cells
A549 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum (all tissue culture reagents purchased from
Gibco-BRL). The A2 strain of RSV was used throughout
this study. Virus was propagated by infecting cells at 70%
confluency at a multiplicity of 0.1 PFU/cell. The virus was
allowed to bind for 1 h; the inoculum was removed and
DMEM with 2% fetal calf serum was added. The infection
was allowed to proceed for 36–48 h at 33°C until cyto-
pathic effect was evident before harvesting for RNA iso-
lation and protein labeling or to produce virus stocks. A
recombinant baculovirus, Bac-Nwt, expressing the N
protein of RSV (details not shown), was grown and titered
on Sf21 cells using TC100 medium with 10% FCS. Sf21
cells were maintained at 28°C. To express N using
Bac-Nwt, Sf21 cells were infected at an m.o.i. of 5 for 72 h
at 28°C.Recombinant protein production
The coding sequences of the N and P protein genes
from human RSV (strain A2) were cloned by PCR from
genomic RNA into the pET 16b bacterial expression
vector (Novagen) to give pETN and pETP (details of
cloning available on request). Subsequent sequencing
demonstrated that the encoded N protein sequence was
identical to that available in GenBank (Accession No.
M74568). The P protein construct had one change from
the published A2 sequence, resulting in an isoleucine-
to-valine change at amino acid position 171. The protein
sequences were in-frame with a histidine tag sequence
which results in the expression of proteins with amino
terminal tags consisting of 10 histidine residues and a
linker of 12 amino acids, containing a Factor Xa protease
cleavage site, before the N and P protein sequence (NHis
and PHis, respectively). The proteins were expressed in
scherichia coli strain BL21 (DE3) pLysS and purified by
ickel affinity chromatography on a Pharmacia Hi-Trap
helating column using a Pharmacia AKTA FPLC system
s per manufacturer’s instructions.
eneration of monoclonal and polyclonal antisera
Polyclonal antisera were raised in New Zealand White
abbits against recombinant NHis and PHis proteins ex-
ressed and purified from E. coli as above. The poly-
lonal antiserum, NRP14, is reactive against RSV N pro-
ein. Monoclonal antibodies to the N protein were raised
n BALB/c mice. A polyclonal antiserum to the P protein
P poly) and a Mab to the P protein (PMab) were also
enerated (details not shown). The Mabs used in this
tudy were purified on a Protein G Hi-Trap column (Phar-
acia) from hybridoma supernatants as per manufactur-
r’s instructions.
eptide scanning
To partially map the epitopes recognized by the mono-
lonal antibodies, a peptide scanning protocol was used.
eptides were synthesized on a Shimadzu automated
eptide synthesizer and purified by HPLC. A total of 26
eptides, each 20 amino acids long (except for the last,
hich was 15 amino acids long), were produced and
urified. Each peptide, designated N1 to N26 (with N1
eing the amino terminus and N26 the carboxyl termi-
us), overlapped with the adjacent peptides by five
mino acids so that each had a core of 10 unique amino
cids. These were used to coat the wells of microtiter
lates overnight at a concentration of 10 mg/ml in PBS at
4°C. After washing and blocking, the antibodies were
added as neat hybridoma supernatants and allowed to
bind for 1 h at room temperature. Bound antibody was
detected using an anti-mouse antibody conjugated to
horseradish peroxidase (HRP). ABTS (1 mg/ml, Sigma)
color reagent in 50 mM citrate buffer (pH 4.0) with hy-
260 MURRAY ET AL.drogen peroxide was added to each well and color
allowed to develop for up to 30 min. All washing and
binding steps were carried out in PBS containing 0.05%
(v/v) Tween 20. The plates were analyzed on a Dynex
microtiter plate reader at a wavelength of 405 nm
(OD405).
Immunofluorescence assay
A549 cells were seeded onto glass coverslips and
infected with RSV at an m.o.i. of 1.0. At 16 h postinfection
the cells were fixed using methanol at 220°C. Alterna-
tively, cycloheximide (100 mg/ml) was added at 16 h
postinfection and cells fixed 2 h later. All washes and
dilutions were carried out using PBS 1 1% (v/v) FCS.
After washing, the Mabs were added at a 1/1000 dilution;
for the polyclonal a 1/500 dilution was employed. After
1 h at room temperature the coverslips were extensively
washed and the appropriate secondary antibody conju-
gated to FITC (Sigma) or Cy5 (Amersham) was added at
a 1/200 dilution. The coverslips were mounted in PBS/
glycerol and viewed with a Zeiss confocal microscope.
Image processing was carried out using the Zeiss LSM
500 software and Adobe PhotoShop.
Radioimmunoprecipitation assay
A549 cells, in a T-180 flask, were infected at an m.o.i.
of 0.1. At 48 h postinfection the cell monolayer was
starved of methionine for 1 h followed by the addition of
[35S]methionine (NEN) at 100 mCi/ml. Cultures were har-
vested 3 h later into lysis buffer (50 mM Tris–HCl pH 8.0,
120 mM NaCl, 0.5% v/v NP-40) and clarified by centrifu-
gation at 10,000 g. The supernatant was then separated
into a soluble and pellet fraction by centrifugation in a
Beckman TLA100.3 rotor at 500,000 g for 30 min; the
pellet was resolubilized into RIPA buffer. The lysates
were precleared using Pansorbin cells (Calbiochem) and
a nonspecific antibody. To the precleared lysates a Mab
or polyclonal antiserum was added and allowed to com-
plex for 1 h at 4°C. Five microliters of a 50% (w/v) solution
of Protein A Sepharose (Pharmacia) was added for a
further 2 h; to precipitate Mab complexes, the Protein A
was preloaded with a rabbit anti-mouse polyclonal. The
bound antibody–antigen complexes were precipitated
and washed five times in lysis buffer and analyzed by
12.5% SDS–PAGE. All binding and washing steps were
carried out at 4°C. Gels were fixed in acetic acid/meth-
anol and dried and the radiolabeled products detected
using a Bio-Rad Personal FX phosphorimager. The Quan-
tity One software (Bio-Rad) was able to perform densi-
tometry on scanned gels. For IP from Bac-Nwt infection,
cells were washed and starved of methionine for 30 min
in methionine-free TC100 medium before labeling as
above. After 3 h at 28°C, the cells were lysed and treated
in the same way as RSV-infected A549 cells.Antibody binding to recombinant nucleocapsids
Sf21 cells infected with Bac-Nwt were lysed in NTE
buffer (150 mM NaCl, 50 mM Tris–HCl pH 7.4, 1 mM
EDTA) with 0.6% (v/v) NP-40 on ice. The lysate was
treated with Rnase A (100 mg/ml21) for 30 min at 37°C.
Nucleocapsids were isolated as described in Iseni et al.
(1998). Briefly clarified lysates were loaded onto a 12-ml
continuous 20–40% (w/w) CsCl gradient and centrifuged
for 16 h at 250,000 g in a Sorvall TST41.14 rotor. The
nucleocapsid band was identified and retrieved by side
puncture of the tube. The presence of nucleocapsid-like
structures was confirmed by electron microscopy. The
nucleocapsids were dialyzed against PBS buffer and
used in a capture ELISA as described above.
N–P interaction
In vitro binding of NHis and PHis proteins was carried out
using an ELISA-based assay. Microtiter plates (Immulon
2, Dynex Technologies) were coated with saturating
amounts, determined empirically, of the P protein over-
night at 4°C. Plates were washed and free protein bind-
ing sites were blocked with 5% (w/v) dried milk powder
(Marvel). NHis protein was added and binding detected
with the polyclonal or monoclonal antisera, followed by
either anti-mouse or anti-rabbit antibody conjugated to
HRP (Sigma); color was developed as above. The spec-
ificity of the N–P binding was confirmed by the inability of
either protein to bind a number of other proteins (e.g.,
GST, BSA, not shown). To test the ability of the Mabs to
bind to preformed nucleocapsids, an ELISA was per-
formed whereby nucleocapsids, isolated from CsCl den-
sity gradients, were captured by Mabs.
Peptide blocking of N–P binding
A saturating amount of PHis protein was used to coat
the wells of microtiter plates overnight at 4°C. After
washing, the peptides were added at varying concentra-
tions from 10 to 100 mg/ml in sextuplet. After binding for
1 h the plates were washed and NHis protein added at
saturating quantities and allowed to interact with PHis.
Bound protein was detected using the anti-N protein
polyclonal NRP14 followed by an anti-rabbit HRP conju-
gate. Color development was described above.
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